Company: JUNS
Filing Date: 2025-10-28
Form Type: PRER14A
Source: 0001493152-25-019793
Chunk: 78

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-10-28
Form: PRER14A
Chunk 78
---
 a Company, which will not be effective until the 65 day after delivery of such written
notice to the Company) of the outstanding shares of Common Stock.

The SEPA will automatically terminate on the earliest
to occur of (i) the 24-month anniversary of the date of the SEPA or (ii) the date on which the Company shall have made full payment of
Advances pursuant to the SEPA. The Company has the right to terminate the SEPA at no cost or penalty upon five trading days’ prior
written notice to Yorkville, provided that there are no outstanding Advance Notices for which shares of common stock need to be issued
and the Company has paid all amounts owed to Yorkville pursuant to the Convertible Notes. The Company and Yorkville may also agree to
terminate the SEPA by mutual written consent. Neither the Company nor Yorkville may assign or transfer any of their respective rights
and obligations under the SEPA, and no provision of the SEPA may be modified or waived by the Company or Yorkville other than by an instrument
in writing signed by both parties.

There are no restrictions on future financings,
rights of first refusal, participation rights, penalties or liquidated damages in the SEPA or Registration Rights Agreement, other than
a prohibition on entering into specified “Variable Rate Transactions” (as such term is defined in the SEPA), other than with
Yorkville, until all outstanding amounts under the Promissory Notes issued under the SEPA have been repaid in full. Such transactions
include, among others, the issuance of convertible securities with a conversion or exercise price that is based upon or varies with the
trading price of the Common Stock after the date of issuance, or the Company effecting or entering into an agreement to effect an “equity
line of credit” or other substantially similar continuous offering with a third party, in which the Company may offer, issue or
sell Common Stock or any securities exercisable, exchangeable or convertible into Common Stock at a future determined price. Furthermore,
under the terms of the SEPA, until all outstanding amounts under the Promissory Notes issued under the SEPA have been repaid in full,
the Company may not repay any loans to any executives or employees of the Company or make any payments in respect of any related party
debt, including outstanding and accrued salaries, except that the Company is permitted to pay (i) an amount equal to one-half of 2022-2024
outstanding bonuses to its executives as